LLY

883.77

-1.52%↓

NVO

141.65

-0.6%↓

UNH

482.82

+0.61%↑

JNJ

148.24

+2.04%↑

MRK

129.72

+1.03%↑

LLY

883.77

-1.52%↓

NVO

141.65

-0.6%↓

UNH

482.82

+0.61%↑

JNJ

148.24

+2.04%↑

MRK

129.72

+1.03%↑

LLY

883.77

-1.52%↓

NVO

141.65

-0.6%↓

UNH

482.82

+0.61%↑

JNJ

148.24

+2.04%↑

MRK

129.72

+1.03%↑

LLY

883.77

-1.52%↓

NVO

141.65

-0.6%↓

UNH

482.82

+0.61%↑

JNJ

148.24

+2.04%↑

MRK

129.72

+1.03%↑

LLY

883.77

-1.52%↓

NVO

141.65

-0.6%↓

UNH

482.82

+0.61%↑

JNJ

148.24

+2.04%↑

MRK

129.72

+1.03%↑

Search

Bausch Health Cos Inc

Closed

Sector Healthcare

6.73 3.7

Overview

Share price change

24h

Current

Min

6.38

Max

6.81

Recommendations

By TipRanks

Recommendations

Neutral

12 Months Forecast

+81.61 upside

Dividends

By Dow Jones

Next Earnings

1 sie 2024

News Sentiment

By Acuity

32%

68%

73 / 369 Ranking in Healthcare

Technical Score

By Trading Central

Confidence

Strong Bullish Evidence

Bausch Health Cos Inc Chart

Related News

30 cze 2023, 12:24 UTC

Top News
Acquisitions, Mergers, Takeovers

Bausch + Lomb's CEO Inks First Big Deal Since Return -- Update

30 cze 2023, 11:00 UTC

Top News
Acquisitions, Mergers, Takeovers

Bausch + Lomb's CEO Inks First Big Deal Since Return -- WSJ

30 cze 2023, 11:00 UTC

Acquisitions, Mergers, Takeovers

Deal Is First Big Acquisition by Bausch CEO Brent Saunders Since Return -- WSJ

30 cze 2023, 11:00 UTC

Acquisitions, Mergers, Takeovers

Bausch Will Buy Xiidra Dry-Eye Drug From Novartis -- WSJ

30 cze 2023, 11:00 UTC

Acquisitions, Mergers, Takeovers

Bausch + Lomb to Pay $1.75 Billion for Eye Drug From Novartis -- WSJ

Peer Comparison

Price change

Bausch Health Cos Inc Forecast

Price Target

By TipRanks

81.61% upside

12 Months Forecast

Average 11.75 USD  81.61%

High 16 USD

Low 9 USD

Based on 5 Wall Street analysts offering 12 month price targets forBausch Health Cos Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Neutral

5 ratings

1

Buy

4

Hold

0

Sell

Technical Score

By Trading Central

6.31 / N/ASupport & Resistance

Short Term

Strong Bullish Evidence

Intermediate Term

Weak Bearish Evidence

Long Term

Bearish Evidence

Sentiment

By Acuity

73 / 369 Ranking in Healthcare

News Sentiment

Bullish Evidence

Volatility

Below average

News Volume (RCV)

Above average